MedPath

Pain and Bleeding Following Hypertonic Saline Sclerotherapy Compared to Brand Ligation for Symptomatic Hemorrhoids

Not Applicable
Withdrawn
Conditions
Pain
Hemorrhoids
Bleeding
Interventions
Procedure: Rubber Band Ligation
Procedure: Hypertonic Saline Infusion
Registration Number
NCT02851940
Lead Sponsor
American University of Beirut Medical Center
Brief Summary

The investigators aim at prospectively comparing procedural pain, adverse events and rebleeding rates of anoscopic rubber band ligation and endoscopic hypertonic saline injection in patients with symptomatic hemorrhoidal disease

Detailed Description

Hemorrhoidal disease is a common encounter in a gastroenterologist's practice. These are often symptomatic, either bleeding or prolapsing. There are no set guidelines in our institution (The American University of Beirut Medical Center - AUBMC) for the treatment of symptomatic hemorrhoidal disease. Two types of treatment are available at our institution: anoscopic rubber band ligation (RBL) or endoscopic sclerotherapy (ESC) with hypertonic (20%) saline. Both methods have been shown to be effective in the literature, with above 75% complete symptomatic relief from a single application after 8-12 months. Post procedural pain of RBL in two randomized studies ranged 40-47%, while different studies showed post procedural pain following ESC to be 12-39%. However no study has ever compared these two therapeutic methods head-on, neither has any study compared both procedures for tolerability and rebleeding rates.

Research design and methods:

This study is a randomized, prospective study conducted at the American University of Beirut Medical Center which will involve 30 patients suffering from symptomatic hemorrhoidal disease requiring therapeutic intervention. Patients meeting inclusion criteria will be randomized using a computer generated randomization list to either Rubber Band Ligation (RBL) or Hypertonic Saline Sclerotherapy as a therapeutic interventional procedure.

- Patients will be approached by their Gastroenterologist during clinic visits and informed about the study. If participants wish to take part in the study, they will be given additional study information, screened for inclusion criteria, and consented by the research assistant or clinic nurse. Recruitment and randomization will occur during the same visit after patient consent in order to properly schedule patients for their therapeutic interventional procedures. All rubber band ligations will be performed by one endoscopist and all sclerotherapies will be performed by the other endoscopist.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Age 18+
  • Consent to the study
  • Bleeding grade 1,2 and 3 hemorrhoids
Exclusion Criteria
  • Age under 18 years
  • Refusal to sign consent
  • Prior surgical and non surgical hemorrhoid procedure/manipulation
  • External hemorrhoids
  • Thrombosed hemorrhoids
  • Active Anal Fissure
  • Active anal fistula
  • Immunocompromised
  • Grade 4 internal hemorrhoids
  • Chronic Pain requiring analgesics
  • Antiplatelets and anticoagulation intake other than Aspirin

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
A (Rubber Band Ligation)Rubber Band Ligation15 patients
B (Hypertonic Saline Infusion)Hypertonic Saline Infusion15 patients
Primary Outcome Measures
NameTimeMethod
Composite Pain ScoreDay 7 after procedure

Range 0 (no pain) to 10 (maximum pain)

Secondary Outcome Measures
NameTimeMethod
Pain Medication UsageDays 1 to 7 after the procedure
Bleedingweek 1-week 7 post procedure, 3 months, 6 months

If any bleeding is noticed upon defecation

Painweek 1-week 7 post procedure, 3 months, 6 months

Range 0 (no pain) to 10 (maximum pain)

Trial Locations

Locations (1)

American University of Beirut Medical Center

🇱🇧

Beirut, Lebanon

© Copyright 2025. All Rights Reserved by MedPath